Verrica Pharmaceuticals: Funding, Investors & Team (Sep 2026)
A pharmaceutical business called Verrica Pharmaceuticals is creating exclusive topical medicines for the treatment of lesional skin illnesses like Molluscum contagiosum and Verruca vulgaris (common warts and plantar warts). Conventional therapies are ineffective, uncomfortable, or necessitate daily compliance for lengthy periods of time before seeing improvements for these and comparable illnesses.
Verrica Pharmaceuticals has raised $5.1M across 1 funding round on record, the most recent an undisclosed round of $5.1M announced in Feb 2023.
That round is in line with the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Verrica Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Verrica Pharmaceuticals Funding Rounds
Verrica Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Verrica Pharmaceuticals Funding Compared to Other Health Care Startups
Verrica Pharmaceuticals' latest round of $5.1M is in line with the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Verrica Pharmaceuticals in Health Care and West Chester
Companies Similar to Verrica Pharmaceuticals
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Verrica Pharmaceuticals Funding FAQs
What does Verrica Pharmaceuticals do?
A pharmaceutical business called Verrica Pharmaceuticals is creating exclusive topical medicines for the treatment of lesional skin illnesses like Molluscum contagiosum and Verruca vulgaris (common warts and plantar warts). Conventional therapies are ineffective, uncomfortable, or necessitate daily compliance for lengthy periods of time before seeing improvements for these and comparable illnesses.
How much funding has Verrica Pharmaceuticals raised?
Verrica Pharmaceuticals has raised $5.1M across 1 round on record. The most recent is an undisclosed round of $5.1M announced in Feb 2023.
When did Verrica Pharmaceuticals last raise funding?
Verrica Pharmaceuticals' most recent funding round on record is an undisclosed round of $5.1M, announced in Feb 2023.
Who is the CEO of Verrica Pharmaceuticals?
Ted White is listed as CEO at Verrica Pharmaceuticals.
Where is Verrica Pharmaceuticals headquartered?
Verrica Pharmaceuticals is based in West Chester, Pennsylvania, United States.
How many employees does Verrica Pharmaceuticals have?
Verrica Pharmaceuticals is in the 11-50 employee band.
How does Verrica Pharmaceuticals' funding compare to other Health Care startups?
Verrica Pharmaceuticals' latest round of $5.1M is in line with the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Verrica Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Verrica Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.